Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of INmune Bio Inc (NASDAQ: INMB) was $7.92 for the day, down -2.10% from the previous closing price of $8.09. In other words, the price has decreased by -$2.10 from its previous closing price. On the day, 0.65 million shares were traded.
Ratios:
Our analysis of INMB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.64 and its Current Ratio is at 2.64. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on January 28, 2025, initiated with a Buy rating and assigned the stock a target price of $23.
On October 21, 2024, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $20.
On September 27, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $18.Raymond James initiated its Outperform rating on September 27, 2024, with a $18 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 30 ’24 when Moss David J bought 10,000 shares for $5.29 per share. The transaction valued at 52,868 led to the insider holds 1,285,869 shares of the business.
Tesi Raymond Joseph bought 15,380 shares of INMB for $98,048 on Sep 12 ’24. The President and CEO now owns 1,554,106 shares after completing the transaction at $6.38 per share. On Sep 12 ’24, another insider, Moss David J, who serves as the Chief Financial Officer of the company, bought 7,690 shares for $6.38 each. As a result, the insider paid 49,024 and bolstered with 1,275,869 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3676.49 while its Price-to-Book (P/B) ratio in mrq is 6.12.
Stock Price History:
Over the past 52 weeks, INMB has reached a high of $10.50, while it has fallen to a 52-week low of $4.32. The 50-Day Moving Average of the stock is 5.03%, while the 200-Day Moving Average is calculated to be 18.12%.
Shares Statistics:
A total of 22.93M shares are outstanding, with a floating share count of 16.50M. Insiders hold about 28.90% of the company’s shares, while institutions hold 25.53% stake in the company.
